Skip to content

Drug interactions

Eliglustat + Mifepristone

Severity: Major

Eliglustat and Mifepristone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mifepristone inhibits CYP3A4 and may raise eliglustat concentrations, and both drugs prolong the QT interval. Higher eliglustat levels can cause arrhythmia.

What this interaction means in plain words

Eliglustat and Mifepristone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Eliglustat belongs to Miscellaneous; Mifepristone belongs to Endocrine.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition increases eliglustat exposure, with additive QT prolongation.

What to do

Avoid if possible; labeling advises dose reduction or avoidance of eliglustat with CYP3A inhibitors depending on CYP2D6 status. Monitor ECG if combined.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Mifepristone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Mifepristone?

MediHelp rates the interaction as major. Eliglustat and Mifepristone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mifepristone inhibits CYP3A4 and may raise eliglustat concentrations, and both drugs prolong the QT interval. Higher eliglustat levels can cause arrhythmia.

How serious is the interaction between Eliglustat and Mifepristone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; labeling advises dose reduction or avoidance of eliglustat with CYP3A inhibitors depending on CYP2D6 status. Monitor ECG if combined.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in